nVerses Capital »

Ocuphire Pharma shares owned by nVerses Capital

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $130k 29k 4.55

More positions owned by nVerses Capital

Lam Research Corp Com New (LRCX)
Ally Financial (ALLY)
Comfort Systems USA (FIX)
Intuitive Surgical Com New (ISRG)
Cintas Corporation (CTAS)
Owl Rock Capital Corporation (OBDC)
Stryker Corporation (SYK)
Jefferies Finl Group (JEF)
Atmus Filtration Technologies Ord (ATMU)
Tsakos Energy Navigation SHS (TEN)
Docusign (DOCU)
A10 Networks (ATEN)
Domino's Pizza (DPZ)
Arista Networks Com Shs (ANET)
Cincinnati Financial Corporation (CINF)

View all positions for nVerses Capital

Top funds holding Ocuphire Pharma

BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Vanguard Group
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Mink Brook Asset Management
Geode Capital Management

View all funds holding Ocuphire Pharma